Neogenomics (NEO) Return on Assets: 2009-2025
Historic Return on Assets for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to -0.08%.
- Neogenomics' Return on Assets fell 3.00% to -0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.08%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.05% for FY2024, which is negligibly% changed negligibly from last year.
- Latest data reveals that Neogenomics reported Return on Assets of -0.08% as of Q3 2025, which was down 17.99% from -0.07% recorded in Q2 2025.
- Neogenomics' Return on Assets' 5-year high stood at 0.04% during Q2 2021, with a 5-year trough of -0.09% in Q3 2022.
- In the last 3 years, Neogenomics' Return on Assets had a median value of -0.05% in 2023 and averaged -0.06%.
- Per our database at Business Quant, Neogenomics' Return on Assets rose by 5bps in 2021 and then fell by 12bps in 2022.
- Neogenomics' Return on Assets (Quarterly) stood at -0.00% in 2021, then declined by 8bps to -0.08% in 2022, then grew by 3bps to -0.05% in 2023, then remained steady at -0.05% in 2024, then dropped by 3bps to -0.08% in 2025.
- Its Return on Assets was -0.08% in Q3 2025, compared to -0.07% in Q2 2025 and -0.05% in Q1 2025.